Imaging and management of nonpalpable lesions of the breast.
Mammography remains the primary imaging modality for the evaluation of breast disease. Its performance level is clearly related to strict quality control measures and comprehensive diagnostic imaging. Ultrasonography remains an adjunct tool for analysing nonpalpable and palpable masses; diagnostic criteria for benign lesions must be strictly applied. Reliable histologic diagnosis is possible with percutaneous large needle core biopsies; benign findings should always be correlated with imaging data and follow-up is essential to detect delayed false negatives. MR imaging is still under evaluation for most indications. Its high sensitivity and negative predictive value are of particular interest for the detection or elimination of breast cancer in selected populations.
Tardivon
A A
AA
Department of Radiology, Institut Gustave-Roussy, 39 rue Camille Desmoulins, 94805 Cedex, Villejuif, France. tardivon@igr.fr
Guinebretière
J M
JM
Dromain
C
C
Vanel
D
D
D001707:Biopsy, Needle; D001941:Breast Diseases / Q000000981:diagnostic imaging* / Q000473:pathology; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008327:Mammography; D016217:Ultrasonography, Mammary